ASA: ​Adding Icosapent Ethyl to Statin Further Cuts Stroke Risk​

FRIDAY, March 12, 2021 -- Icosapent ethyl (IPE) can further reduce the risk for stroke for statin-treated patients with elevated triglycerides and the risk or evidence of atherosclerosis, according to a study presented at the American Stroke...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news